Dynamic light scattering (DLS) is an analytical technique used to understand how small particles behave in a liquid. When particles such as nanoparticles, emulsions, liposomes, proteins, polymers, or colloids move randomly in solution, they scatter laser light in constantly changing patterns. By analyzing these light fluctuations, DLS can estimate hydrodynamic particle size, size distribution trends, polydispersity, aggregation behavior, and dispersion stability. Because it requires only a liquid sample and provides rapid particle-size information, DLS is widely used in pharmaceutical formulation, nanomedicine development, protein and polymer research, cosmetics, specialty chemicals, and advanced materials. BOC Sciences provides customized DLS testing services to help clients evaluate particle size, PDI, zeta potential, aggregation tendency, formulation comparability, storage-related size change, and colloidal stability. Through an integrated analytical platform, our scientists connect DLS results with practical development decisions for formulation screening, process optimization, material selection, and troubleshooting of complex dispersed systems.
BOC Sciences provides DLS-based particle size distribution testing for liquid dispersions where clients need fast, reproducible insight into hydrodynamic size, size trend, and dispersion quality. This service supports early formulation screening, batch comparison, process optimization, and material selection when nanoscale or submicron particles must be evaluated in their dispersed state.
DLS is highly sensitive to larger scattering populations, making it valuable for detecting early aggregation, formulation incompatibility, salt-induced instability, temperature-related growth, and storage-dependent particle change. BOC Sciences designs DLS workflows that compare conditions rather than relying on a single isolated size result.
For many dispersed systems, particle size alone does not explain instability. BOC Sciences supports zeta potential testing by electrophoretic light scattering to evaluate surface charge-related behavior, electrostatic repulsion, dispersion tendency, and formulation sensitivity across selected media and preparation conditions.
Many DLS difficulties come from dust, poor dispersion, concentration effects, multiple scattering, viscosity mismatch, fluorescent samples, colored media, or mixed particle populations. BOC Sciences optimizes sample handling and measurement strategy to improve data reliability for real-world pharmaceutical, chemical, biological, and materials samples.
BOC Sciences helps clients obtain robust DLS data, minimize sample artifacts, interpret particle size and zeta potential trends, and connect light scattering results with formulation, synthesis, material, or process decisions.
We apply suitable scattering angle strategies to evaluate particle size behavior in dilute, moderately turbid, weakly scattering, and heterogeneous samples, improving flexibility for formulation and material systems.
BOC Sciences reviews correlation functions, count rate, Z-average size, PDI, and distribution outputs to avoid overinterpreting a single value, especially for broad or multimodal samples.
Zeta potential testing supports evaluation of surface charge behavior, electrostatic stability, formulation sensitivity, and charge-shift trends in nanoparticles, emulsions, liposomes, and polymer colloids.
We can design time-course and temperature-dependent DLS studies to monitor aggregation kinetics, particle growth, dispersion recovery, and formulation robustness under selected experimental conditions.
BOC Sciences supports analytical method optimization for dilution, dispersant selection, filtration, centrifugation, equilibration, viscosity input, cuvette choice, and measurement sequence.
DLS data can be combined with complementary analytical technologies, including chromatography, microscopy, spectroscopy, thermal analysis, surface analysis, and elemental characterization.
DLS testing requires close alignment between sample chemistry, particle concentration, dispersant, viscosity, expected size range, optical properties, and the client's development question. BOC Sciences adapts DLS workflows for each project so that particle size data are not only repeatable but also meaningful for formulation screening, material comparison, aggregation investigation, dispersion optimization, or stability-related decision-making.
Share your sample matrix, expected size range, particle concentration, dispersant, viscosity, solvent environment, formulation variables, and decision objective. Our specialists will design a project-specific method development plan for reliable DLS preparation, measurement, data review, and interpretation.
We review the sample type, target particle population, expected hydrodynamic size range, solvent or buffer composition, optical appearance, viscosity, concentration, particle sensitivity, formulation variables, and comparison groups to define whether DLS testing should focus on size distribution, aggregation, PDI, zeta potential, temperature response, or dispersion stability.
We select suitable preparation conditions such as dilution ratio, dispersant, buffer blank, filtration, centrifugation, sonication, equilibration, degassing, temperature setting, cuvette type, measurement angle, and replicate plan. For zeta potential studies, electrode cell selection, conductivity range, and dispersant compatibility are also considered.
We acquire repeated DLS measurements under defined conditions, monitor count rate, attenuation, correlation function shape, run-to-run variation, baseline behavior, and size distribution consistency. When needed, concentration series, temperature ramps, time-course measurements, or zeta potential testing are added to understand sample-dependent behavior.
Our team summarizes Z-average diameter, Dh, PDI, distribution profiles, zeta potential, measurement conditions, replicate statistics, sample preparation notes, and data-quality considerations. Results are interpreted according to formulation selection, material comparison, aggregation investigation, dispersion optimization, process troubleshooting, or stability study objectives.
DLS is extremely sensitive to large scatterers, so dust, bubbles, loose particulates, or a few aggregates can dominate the reported intensity distribution. BOC Sciences reduces this risk through blank review, controlled filtration or centrifugation when appropriate, clean handling, replicate aliquots, count-rate monitoring, and interpretation of correlation-function behavior rather than size output alone.
Broad or multimodal samples can produce DLS results that are easy to misread, especially when intensity, volume, and number distributions appear different. Our workflow emphasizes PDI, correlation-function quality, size trend, dilution response, and complementary evidence, helping clients avoid overinterpreting small subpopulations or software-converted distribution profiles.
Highly concentrated or strongly scattering dispersions may cause multiple scattering, apparent size inflation, poor baseline behavior, or inconsistent run results. We evaluate concentration series, attenuation settings, dilution linearity, scattering intensity, and sample recovery to identify measurement windows that better represent the dispersed particle population.
Clients often need to know whether a formulation change reduces aggregation, whether a surfactant improves dispersion, whether a storage condition causes particle growth, or whether zeta potential shifts explain instability. BOC Sciences interprets DLS findings in the context of the client's formulation history, material chemistry, and next experimental decisions.
Collaborate with BOC Sciences to design DLS experiments that reveal hydrodynamic size, PDI, aggregation behavior, zeta potential trends, formulation sensitivity, and dispersion stability with clear, decision-ready interpretation.
BOC Sciences does not use a one-condition-fits-all sizing approach. We design dilution, dispersant, filtration, equilibration, temperature, zeta potential, and replicate measurement strategies according to sample chemistry, scattering intensity, matrix composition, and the client's analytical objective.
Our team supports API analysis, nanoscale formulation characterization, protein aggregation review, emulsion stability comparison, particle-size troubleshooting, and dispersion studies for discovery, formulation, and product development teams.
BOC Sciences provides not only Z-average diameter and PDI values but also correlation-function review, replicate assessment, distribution interpretation, artifact discussion, zeta potential context, and practical recommendations for formulation design and screening.
DLS results can be connected with stability studies, microscopy, chromatography, surface charge testing, rheology, thermal behavior, compatibility assessment, and broader particle characterization when clients need a complete view of dispersed systems.
Client Needs: A formulation development team working on an ionizable lipid nanoparticle system needed to compare hydrodynamic size, PDI, and zeta potential across buffer conditions and identify whether size growth was driven by excipient selection or handling conditions.
Challenges: The samples were concentration-sensitive and showed occasional high-intensity peaks from larger scatterers. Direct dilution changed ionic strength, while insufficient dilution produced inconsistent count rates and broad PDI values.
Solution: We designed a matched-buffer dilution matrix, measured three concentration levels for 18 formulation lots, and paired backscatter DLS with electrophoretic light scattering. More than 160 correlation functions were reviewed for count-rate consistency, baseline behavior, and repeatability. Z-average, PDI, intensity distribution, and zeta potential trends were then mapped against lipid ratio and buffer composition.
Outcome: The study showed that two buffer compositions increased aggregation tendency, while one excipient ratio maintained a narrower size distribution and more stable surface-charge profile.
Client Needs: A materials research group developing polymer nanoparticles needed to determine whether a pH-responsive coating caused reversible swelling or irreversible aggregation during solvent exchange and salt exposure.
Challenges: The polymer particles showed broad scattering profiles after solvent exchange. Large-particle signals appeared intermittently, and the client needed evidence that separated true aggregation from preparation-related particulates.
Solution: We screened dispersant composition, pH, ionic strength, sonication duration, and filtration controls before final DLS acquisition. Across 72 DLS runs, we compared size recovery after dilution, salt challenge, and pH reversal. Correlation-function quality and intensity distribution tails were reviewed together with zeta potential shifts to distinguish reversible swelling from irreversible clustering.
Outcome: The analysis confirmed that moderate pH change produced reversible swelling, while high salt exposure triggered persistent aggregation, guiding the client's coating and dispersant selection.
Client Needs: A personal care formulation team needed to compare droplet size stability in a nanoemulsion system containing fragrance oil, surfactant blend, and polymer thickener under different storage and mixing conditions.
Challenges: The emulsion matrix was viscous and slightly turbid, causing scattering intensity variation. Droplet size changed with dilution conditions, making direct comparison between batches difficult without a consistent measurement protocol.
Solution: We developed a viscosity-corrected DLS workflow using controlled dilution, matched aqueous phase, temperature equilibration, and replicate cuvettes. Forty emulsion batches were tested before and after storage challenge, generating more than 240 size measurements. Droplet size, PDI, count rate, and distribution broadening were compared with mixing speed, surfactant ratio, and thickener level.
Outcome: The results identified one surfactant-to-oil ratio with lower droplet growth and narrower PDI, helping the client prioritize a more robust emulsion composition.
DLS Testing, or dynamic light scattering testing, is an analytical method used to measure the hydrodynamic particle size and particle size distribution of dispersed systems. Its principle is clear: nanoparticles suspended in a liquid move randomly due to Brownian motion. When a laser beam passes through the sample, the intensity of scattered light fluctuates over time. By analyzing the autocorrelation function of these fluctuations, the instrument calculates the diffusion coefficient of the particles and converts it into hydrodynamic diameter using the Stokes–Einstein equation. DLS is especially useful for rapid size assessment of nanoparticles, colloids, protein aggregates, liposomes, polymeric micelles, and emulsions.
DLS Testing typically provides the average hydrodynamic particle size, particle size distribution trend, polydispersity index (PDI), and evidence of large particles or aggregates in a sample. Hydrodynamic size reflects how particles diffuse in a liquid environment, which may differ from the geometric size obtained by dry-state imaging methods such as TEM or SEM. PDI helps evaluate whether a dispersion is uniform; a lower PDI generally indicates a narrower size distribution. For nanoformulations, colloidal materials, and polymer dispersions, DLS data can be used to compare how formulation, process, solvent, pH, or storage conditions affect particle stability.
In drug development, DLS Testing is commonly used to characterize lipid nanoparticles, liposomes, polymeric nanoparticles, nanosuspensions, micelles, and protein drug aggregates. It helps researchers determine whether a drug delivery system has formed within the expected particle size range, whether formulation changes cause particle growth, and whether aggregation or broadening of size distribution occurs. For example, during lipid nanoparticle or nanocarrier screening, DLS can compare particle size changes under different lipid ratios, buffer systems, mixing conditions, and storage environments, supporting formulation optimization and stability evaluation.
DLS Testing is suitable for particle systems that can remain stably dispersed in a liquid phase. Typical samples include nanoparticles, colloidal particles, emulsions, liposomes, protein complexes, polymeric micelles, metal oxide particles, silica particles, and functionalized nanomaterials. Samples usually need appropriate concentration, good dispersibility, and limited sedimentation tendency. For dark-colored, strongly absorbing, highly viscous, impurity-rich, or extremely broad-distribution samples, dilution conditions, dispersion methods, and test parameters may need optimization to reduce the effects of multiple scattering, sedimentation, or large-particle interference.
BOC Sciences designs suitable DLS Testing strategies according to sample type, expected particle size, dispersion medium, concentration range, and the client’s research objective. For samples that are prone to aggregation, sedimentation, or dilution sensitivity, we optimize sample concentration, filtration or centrifugation strategy, equilibration time, test temperature, replicate measurements, and data analysis model. For pharmaceutical nanoformulations and functional material samples, we provide not only particle size and PDI data, but also context-based interpretation of size changes, aggregation trends, and relationships between formulation or process factors, helping clients obtain more decision-ready analytical results.
We needed more than a simple particle size number. BOC Sciences reviewed the DLS correlation data, compared dilution conditions, and explained which aggregation signals were real enough to affect our formulation screen.
— Dr. Lehtinen, Formulation Development Scientist
Our polymer dispersion gave inconsistent DLS results before we contacted BOC Sciences. Their team optimized the sample preparation and provided a practical interpretation of size, PDI, and zeta potential trends.
— Becker, Materials Project Lead
The combination of DLS sizing and zeta potential testing helped us understand why one emulsion condition was less stable. The report connected charge behavior, droplet growth, and formulation variables clearly.
— Yoon, Senior Research Chemist
BOC Sciences did not simply send instrument outputs. They explained sample artifacts, checked repeatability, compared storage conditions, and helped our team decide which dispersion strategy deserved further development.
— Hoffmann, Analytical Development Manager
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
